Dr. Jimmy Potash, director of psychiatry and behavioral sciences at Johns Hopkins School of Medicine, will review recent developments in research on psychedelics in psychiatry, especially in MDMA (commonly known as “ecstasy” or “molly”) for PTSD and psilocybin (psychoactive “mushrooms”) to treat depression and addictions.